跳至主要内容
临床试验/DRKS00026906
DRKS00026906招募中不适用

Extract Study by Cannamedical about Pain Ease - ESCAPE

Cannamedical Pharma GmbH0 个研究点目标入组 500 人开始时间: 2022年3月11日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • 1. Age = 18 years
  • 2. Presence of chronic pain
  • 3. Previous pain therapies have not been successful due to side effects, insufficient dose, due to side effects, drug interactions or pre-existing conditions, allergic reactions
  • 4. No previous therapy with the Cannamedical-Extract
  • 5. Prescription of medicinal cannabis is indicated
  • 6. Patients who—after having been informed by their physician—have signed the consent and privacy policy.

排除标准

  • 1. Existing recreational cannabis use in the last 6 months
  • 2. Existing recreational drug use in the last 6 months
  • 3. Presence of schizophrenia, psychosis, or other psychiatric diseases
  • 4. Known allergies to ingredients or carriers.
  • 5. Presence of pregnancy and lactation and women who are planning to become pregnant during
  • 6. Simultaneous participation in another study
  • 7. Patients who are not capable of giving consent
  • 8. Imprisoned or under-age patients
  • 9. Persons who do not speak German

研究者

发起方
Cannamedical Pharma GmbH

相似试验